|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Acacia Research Corp., of Newport Beach, Calif., obtained commitments from buyers who will purchase $15 million of its Acacia Research-CombiMatrix common stock in a registered direct offering. Acacia will sell 3 million shares at $5 each to a group of institutional investors in an offering expected to close on or about April 15. CombiMatrix will receive $13.6 million through the sale, in which all the shares are being offered by Acacia. Thomas Weisel Partners LLC acted as the offering's exclusive lead placement agent, with Brean Murray & Co. as exclusive co-placement agent. CombiMatrix is developing a platform technology to produce biochips, with applications in DNA ...